Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163148 · ClinicalTrials.gov registry record
Predictors of Exposure Success in Public Speaking Anxiety
A clinical trial of Performance Anxiety, sponsored by University of California, San Diego.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT02163148: Completed study of Performance Anxiety, sponsored by University of California, San Diego.
NCT02163148 is a study of Performance Anxiety that has completed, run by University of California, San Diego. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02163148, a study of Performance Anxiety, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety disorders are common and impairing. Although exposure therapy is one of the most effective treatments for anxiety, some individuals do not fully respond to treatment, and these individual differences are not well understood. Exposure therapy involves repeated, deliberate, safe engagement with a feared stimulus without the feared outcome occurring. This treatment is thought to work through a type of emotional learning called fear extinction. This study aims to look at links between fear extinction learning and exposure success, with the overall goal of better understanding who is likely to respond best to exposure therapy and why.
Primary Outcome
Participants will complete 4 exposures during one 90 minute session. Change in the peak ratings on the final exposure relative to the first exposure will be the outcome measure.
Conditions Studied
Interventions
- BEHAVIORAL Massed speech exposure session
Study Locations (1)
California
- UCSD Psychiatry Research - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-12 |
What the finished NCT02163148 record still lists
NCT02163148 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 1 condition, with Performance Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Massed speech exposure session is the first listed.
NCT02163148 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02163148 about?
NCT02163148 is a clinical study titled "Predictors of Exposure Success in Public Speaking Anxiety". Anxiety disorders are common and impairing. Although exposure therapy is one of the most effective treatments for anxiety, some individuals do not fully respond to treatment, and these individual differences are not well understood. Exposure therapy involves repeated, deliberate, safe engagement wit...
What is the current status of trial NCT02163148?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2014-05. Estimated completion is 2014-12.
What conditions does trial NCT02163148 study?
This clinical trial studies the following conditions: Performance Anxiety.
What interventions are being tested in trial NCT02163148?
The interventions under investigation include: Massed speech exposure session (BEHAVIORAL).
Who is sponsoring clinical trial NCT02163148?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02163148 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Performance Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia